<DOC>
	<DOCNO>NCT00003580</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Drugs amifostine may protect normal cell side effect chemotherapy radiation therapy . PURPOSE : Phase II trial study effectiveness amifostine treat side effect treatment patient receive radiation therapy cisplatin advance head neck cancer .</brief_summary>
	<brief_title>Amifostine Treat Side Effects Treatment Patients Receiving Radiation Therapy Cisplatin Advanced Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy amifostine alleviate treatment relate mucositis associate target supradose cisplatin concurrent radiotherapy ( RADPLAT protocol ) patient stage III IV squamous cell carcinoma head neck . II . Determine efficacy amifostine alleviate treatment related morbidity associate protocol patient . OUTLINE : This open label , multicenter study amifostine . Patients receive external beam radiotherapy 5 day week approximately 6.5-7.5 week . Concurrent radiotherapy , patient receive amifostine IV 10 minute , 30 minute prior cisplatin , cisplatin intra-arterially 3-5 minute . Chemotherapy amifostine course repeat every week 4 week . Patients follow 1 month . PROJECTED ACCRUAL : Approximately 30 patient accrue study 12-18 month .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma oral cavity , nasopharynx , oropharynx , hypopharynx , larynx Previously untreated Stage III IV No distant metastatic disease PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : WBC least 3,500/mm3 Platelet count least 100,000/mm3 Hepatic : SGOT SGPT great 2.5 time upper limit normal Renal : Creatinine great 2.0 mg/dL Creatinine clearance great 61 mL/min Other : No history underlie medical psychiatric illness Not pregnant nursing Effective contraception require fertile patient PRIOR CONCURRENT THERAPY : No prior therapy head neck cancer Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : At least 24 hour since prior antihypertensive medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>oral complication</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>drug/agent toxicity tissue/organ</keyword>
	<keyword>radiation toxicity</keyword>
</DOC>